Exact Mass: 463.2042
Exact Mass Matches: 463.2042
Found 500 metabolites which its exact mass value is equals to given mass value 463.2042
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
4-Hydroxynonenal glutathione
4-Hydroxynonenal glutathione (4-HNE-GSH) is the conjugated product of 4-hydroxy-2-nonenal with glutathione that is synthesized from a reaction catalyzed by glutathione transferases (GSTs). 4-Hydroxy-2-nonenal (4-HNE) is a major lipid peroxidation end product that is known to be highly toxic and very stable. It has been implicated in the pathogenesis and progression of a multitude of human diseases (e.g. cataractogenesis, diabetes, atherosclerosis, osteoporosis, Alzheimers disease, Parkinsons disease, multiple schlerosis, cancer, etc.) (PMID: 23848536). The primary mechanism of 4-HNE detoxification is via its conjugation to glutathione (PMID: 12892994).
Tafenoquine
Lys Ser Asp Asp
Asp Ser Lys Asp
C26H29N3O5_3-Hydroxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0~1,17~.0~3,15~.0~4,13~.0~7,12~.0~19,23~]hexacosa-4,6,10,12,14-pentaene-24,26-dione 14-oxide
Ala Asp Lys Met
Ala Asp Met Lys
Ala Lys Asp Met
Ala Lys Met Asp
Ala Met Asp Lys
Ala Met Lys Asp
Ala Asn Pro Tyr
Ala Asn Tyr Pro
Ala Pro Asn Tyr
Ala Pro Tyr Asn
Ala Ser Thr Trp
Ala Ser Trp Thr
Ala Thr Ser Trp
Ala Thr Trp Ser
Ala Trp Ser Thr
Ala Trp Thr Ser
Ala Tyr Asn Pro
Ala Tyr Pro Asn
Cys Asp Lys Val
Cys Asp Val Lys
Cys Ile Gln Thr
Cys Ile Thr Gln
Cys Lys Asp Val
Cys Lys Val Asp
Cys Leu Gln Thr
Cys Leu Thr Gln
Cys Gln Ile Thr
Cys Gln Leu Thr
Cys Gln Thr Ile
Cys Gln Thr Leu
Cys Thr Ile Gln
Cys Thr Leu Gln
Cys Thr Gln Ile
Cys Thr Gln Leu
Cys Val Asp Lys
Cys Val Lys Asp
Asp Ala Lys Met
Asp Ala Met Lys
Asp Cys Lys Val
Asp Cys Val Lys
Asp Asp Lys Ser
Asp Asp Ser Lys
Asp Lys Ala Met
Asp Lys Cys Val
Asp Lys Asp Ser
Asp Lys Met Ala
Asp Lys Ser Asp
Asp Lys Val Cys
Asp Met Ala Lys
Asp Met Lys Ala
Asp Gln Thr Thr
Asp Arg Ser Ser
Asp Ser Asp Lys
Asp Ser Arg Ser
Asp Ser Ser Arg
Asp Thr Gln Thr
Asp Thr Thr Gln
Asp Val Cys Lys
Asp Val Lys Cys
Glu Gly Lys Met
Glu Gly Met Lys
Glu Lys Gly Met
Glu Lys Met Gly
Glu Met Gly Lys
Glu Met Lys Gly
Glu Asn Thr Thr
Glu Gln Ser Thr
Glu Gln Thr Ser
Glu Ser Gln Thr
Glu Ser Thr Gln
Phe Asn Pro Ser
Phe Asn Ser Pro
Phe Pro Asn Ser
Phe Pro Ser Asn
Phe Ser Asn Pro
Phe Ser Pro Asn
Gly Glu Lys Met
Gly Glu Met Lys
Gly His His Asn
Gly His Asn His
Gly Lys Glu Met
Gly Lys Met Glu
Gly Met Glu Lys
Gly Met Lys Glu
Gly Asn His His
Gly Pro Gln Tyr
Gly Pro Tyr Gln
Gly Gln Pro Tyr
Gly Gln Tyr Pro
Gly Thr Thr Trp
Gly Thr Trp Thr
Gly Trp Thr Thr
Gly Tyr Pro Gln
Gly Tyr Gln Pro
His Gly His Asn
His Gly Asn His
His His Gly Asn
His His Asn Gly
His Asn Gly His
His Asn His Gly
Ile Cys Gln Thr
Ile Cys Thr Gln
Ile Met Asn Ser
Ile Met Ser Asn
Ile Asn Met Ser
Ile Asn Ser Met
Ile Gln Cys Thr
Ile Gln Thr Cys
Ile Ser Met Asn
Ile Ser Asn Met
Ile Thr Cys Gln
Ile Thr Gln Cys
Lys Ala Asp Met
Lys Ala Met Asp
Lys Cys Asp Val
Lys Cys Val Asp
Lys Asp Ala Met
Lys Asp Cys Val
Lys Asp Met Ala
Lys Asp Val Cys
Lys Glu Gly Met
Lys Glu Met Gly
Lys Gly Glu Met
Lys Gly Met Glu
Lys Met Ala Asp
Lys Met Asp Ala
Lys Met Glu Gly
Lys Met Gly Glu
Lys Val Cys Asp
Lys Val Asp Cys
Leu Cys Gln Thr
Leu Cys Thr Gln
Leu Met Asn Ser
Leu Met Ser Asn
Leu Asn Met Ser
Leu Asn Ser Met
Leu Gln Cys Thr
Leu Gln Thr Cys
Leu Ser Met Asn
Leu Ser Asn Met
Leu Thr Cys Gln
Leu Thr Gln Cys
Met Ala Asp Lys
Met Ala Lys Asp
Met Asp Ala Lys
Met Asp Lys Ala
Met Glu Gly Lys
Met Glu Lys Gly
Met Gly Glu Lys
Met Gly Lys Glu
Met Ile Asn Ser
Met Ile Ser Asn
Met Lys Ala Asp
Met Lys Asp Ala
Met Lys Glu Gly
Met Lys Gly Glu
Met Leu Asn Ser
Met Leu Ser Asn
Met Asn Ile Ser
Met Asn Leu Ser
Met Asn Ser Ile
Met Asn Ser Leu
Met Asn Thr Val
Met Asn Val Thr
Met Gln Ser Val
Met Gln Val Ser
Met Ser Ile Asn
Met Ser Leu Asn
Met Ser Asn Ile
Met Ser Asn Leu
Met Ser Gln Val
Met Ser Val Gln
Met Thr Asn Val
Met Thr Val Asn
Met Val Asn Thr
Met Val Gln Ser
Met Val Ser Gln
Met Val Thr Asn
Asn Ala Pro Tyr
Asn Ala Tyr Pro
Asn Glu Thr Thr
Asn Phe Pro Ser
Asn Phe Ser Pro
Asn Gly His His
Asn His Gly His
Asn His His Gly
Asn Ile Met Ser
Asn Ile Ser Met
Asn Leu Met Ser
Asn Leu Ser Met
Asn Met Ile Ser
Asn Met Leu Ser
Asn Met Ser Ile
Asn Met Ser Leu
Asn Met Thr Val
Asn Met Val Thr
Asn Pro Ala Tyr
Asn Pro Phe Ser
Asn Pro Ser Phe
Asn Pro Tyr Ala
Asn Ser Phe Pro
Asn Ser Ile Met
Asn Ser Leu Met
Asn Ser Met Ile
Asn Ser Met Leu
Asn Ser Pro Phe
Asn Thr Glu Thr
Asn Thr Met Val
Asn Thr Thr Glu
Asn Thr Val Met
Asn Val Met Thr
Asn Val Thr Met
Asn Tyr Ala Pro
Asn Tyr Pro Ala
Pro Ala Asn Tyr
Pro Ala Tyr Asn
Pro Phe Asn Ser
Pro Phe Ser Asn
Pro Gly Gln Tyr
Pro Gly Tyr Gln
Pro Asn Ala Tyr
Pro Asn Phe Ser
Pro Asn Ser Phe
Pro Asn Tyr Ala
Pro Gln Gly Tyr
Pro Gln Tyr Gly
Pro Ser Phe Asn
Pro Ser Asn Phe
Pro Tyr Ala Asn
Pro Tyr Gly Gln
Pro Tyr Asn Ala
Pro Tyr Gln Gly
Gln Cys Ile Thr
Gln Cys Leu Thr
Gln Cys Thr Ile
Gln Cys Thr Leu
Gln Asp Thr Thr
Gln Glu Ser Thr
Gln Glu Thr Ser
Gln Gly Pro Tyr
Gln Gly Tyr Pro
Gln Ile Cys Thr
Gln Ile Thr Cys
Gln Leu Cys Thr
Gln Leu Thr Cys
Gln Met Ser Val
Gln Met Val Ser
Gln Pro Gly Tyr
Gln Pro Tyr Gly
Gln Ser Glu Thr
Gln Ser Met Val
Gln Ser Thr Glu
Gln Ser Val Met
Gln Thr Cys Ile
Gln Thr Cys Leu
Gln Thr Asp Thr
Gln Thr Glu Ser
Gln Thr Ile Cys
Gln Thr Leu Cys
Gln Thr Ser Glu
Gln Thr Thr Asp
Gln Val Met Ser
Gln Val Ser Met
Gln Tyr Gly Pro
Gln Tyr Pro Gly
Arg Asp Ser Ser
Arg Ser Asp Ser
Arg Ser Ser Asp
Ser Ala Thr Trp
Ser Ala Trp Thr
Ser Asp Asp Lys
Ser Asp Lys Asp
Ser Asp Arg Ser
Ser Asp Ser Arg
Ser Glu Gln Thr
Ser Glu Thr Gln
Ser Phe Asn Pro
Ser Phe Pro Asn
Ser Ile Met Asn
Ser Ile Asn Met
Ser Lys Asp Asp
Ser Leu Met Asn
Ser Leu Asn Met
Ser Met Ile Asn
Ser Met Leu Asn
Ser Met Asn Ile
Ser Met Asn Leu
Ser Met Gln Val
Ser Met Val Gln
Ser Asn Phe Pro
Ser Asn Ile Met
Ser Asn Leu Met
Ser Asn Met Ile
Ser Asn Met Leu
Ser Asn Pro Phe
Ser Pro Phe Asn
Ser Pro Asn Phe
Ser Gln Glu Thr
Ser Gln Met Val
Ser Gln Thr Glu
Ser Gln Val Met
Ser Arg Asp Ser
Ser Arg Ser Asp
Ser Ser Asp Arg
Ser Ser Arg Asp
Ser Thr Ala Trp
Ser Thr Glu Gln
Ser Thr Gln Glu
Ser Thr Trp Ala
Ser Val Met Gln
Ser Val Gln Met
Ser Trp Ala Thr
Ser Trp Thr Ala
Thr Ala Ser Trp
Thr Ala Trp Ser
Thr Cys Ile Gln
Thr Cys Leu Gln
Thr Cys Gln Ile
Thr Cys Gln Leu
Thr Asp Gln Thr
Thr Asp Thr Gln
Thr Glu Asn Thr
Thr Glu Gln Ser
Thr Glu Ser Gln
Thr Glu Thr Asn
Thr Gly Thr Trp
Thr Gly Trp Thr
Thr Ile Cys Gln
Thr Ile Gln Cys
Thr Leu Cys Gln
Thr Leu Gln Cys
Thr Met Asn Val
Thr Met Val Asn
Thr Asn Glu Thr
Thr Asn Met Val
Thr Asn Thr Glu
Thr Asn Val Met
Thr Gln Cys Ile
Thr Gln Cys Leu
Thr Gln Asp Thr
Thr Gln Glu Ser
Thr Gln Ile Cys
Thr Gln Leu Cys
Thr Gln Ser Glu
Thr Gln Thr Asp
Thr Ser Ala Trp
Thr Ser Glu Gln
Thr Ser Gln Glu
Thr Ser Trp Ala
Thr Thr Asp Gln
Thr Thr Glu Asn
Thr Thr Gly Trp
Thr Thr Asn Glu
Thr Thr Gln Asp
Thr Thr Trp Gly
Thr Val Met Asn
Thr Val Asn Met
Thr Trp Ala Ser
Thr Trp Gly Thr
Thr Trp Ser Ala
Thr Trp Thr Gly
Val Cys Asp Lys
Val Cys Lys Asp
Val Asp Cys Lys
Val Asp Lys Cys
Val Lys Cys Asp
Val Lys Asp Cys
Val Met Asn Thr
Val Met Gln Ser
Val Met Ser Gln
Val Met Thr Asn
Val Asn Met Thr
Val Asn Thr Met
Val Gln Met Ser
Val Gln Ser Met
Val Ser Met Gln
Val Ser Gln Met
Val Thr Met Asn
Val Thr Asn Met
Trp Ala Ser Thr
Trp Ala Thr Ser
Trp Gly Thr Thr
Trp Ser Ala Thr
Trp Ser Thr Ala
Trp Thr Ala Ser
Trp Thr Gly Thr
Trp Thr Ser Ala
Trp Thr Thr Gly
Tyr Ala Asn Pro
Tyr Ala Pro Asn
Tyr Gly Pro Gln
Tyr Gly Gln Pro
Tyr Asn Ala Pro
Tyr Asn Pro Ala
Tyr Pro Ala Asn
Tyr Pro Gly Gln
Tyr Pro Asn Ala
Tyr Pro Gln Gly
Tyr Gln Gly Pro
Tyr Gln Pro Gly
Aspergamide A
OPC 31260 HCl
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist D045283 - Natriuretic Agents > D065092 - Antidiuretic Hormone Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents
4-[1-dimethylamino-3-[2-[2-(3-ethylphenyl)ethyl]phenoxy]propan-2-yl]ox y-4-oxo-butanoic acid hydrochloride
Tafenoquine
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BA - Aminoquinolines D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
1-(2-Fluorobenzyl)-3-butyl-8-(N-acetyl-4-aminobenzyl)-xanthine
6-{4-[(1-{[5-(4-Methoxyphenyl)-1,3,4-oxadiazol-2-yl]carbonyl}azetidin-3-yl)oxy]benzyl}-2-oxa-6-azoniaspiro[3.3]heptane
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-(4-hydroxy-1-oxononan-3-yl)sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
4-methyl-N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide
5-(dimethylsulfamoyl)-N-(diphenylmethyl)-2-(1-pyrrolidinyl)benzamide
5-Methyl-4-[(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)-[1-(1-naphthalenylmethyl)-3-indolyl]methyl]-1,2-dihydropyrazol-3-one
1-[5-(Diethylsulfamoyl)-2-(4-methyl-1-piperazinyl)phenyl]-3-(2-fluorophenyl)urea
2-[(5,5-dimethyl-6H-[1,2,4]triazolo[3,4-a]isoquinolin-3-yl)thio]-1-[4-(2-methoxyphenyl)-1-piperazinyl]ethanone
3,17beta-dihydroxyestra-1,3,5(10)-trien-2-yl beta-D-glucopyranosiduronate
16alpha,17alpha-dihydroxyestra-1(10),2,4-trien-3-yl beta-D-glucopyranosiduronate
Glycine, L-gamma-glutamyl-S-[2-hydroxy-1-(2-oxoethyl)heptyl]-L-cysteinyl-
3,16alpha-dihydroxyestra-1(10),2,4-trien-17alpha-yl beta-D-glucopyranosiduronate
16beta,17beta-dihydroxyestra-1(10),2,4-trien-3-yl beta-D-glucopyranosiduronate
3,17beta-dihydroxyestra-1(10),2,4-trien-4-yl beta-D-glucopyranosiduronate
estriol 16-O-(beta-D-glucuronide)(1-)
A steroid glucuronide anion that is the conjugate base of estriol 16-O-(beta-D-glucuronide) arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
3,17alpha-dihydroxyestra-1(10),2,4-trien-16alpha-yl beta-D-glucopyranosiduronate
3,17beta-dihydroxyestra-1(10),2,4-trien-16beta-yl beta-D-glucopyranosiduronate
2,17beta-dihydroxyestra-1,3,5(10)-trien-3-yl beta-D-glucopyranosiduronate
4,17beta-dihydroxyestra-1(10),2,4-trien-3-yl beta-D-glucopyranosiduronate
2-[2-[2-[(4-Tert-butyl-2,6-dimethylphenyl)thio]ethyl]-1-pyridin-1-iumyl]-1-(4-nitrophenyl)ethanone
N4-(2-amino-5-thiophen-2-ylphenyl)-N1-[2-(4-methyl-1-piperazinyl)ethyl]benzene-1,4-dicarboxamide
(4R)-4-N-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]pentane-1,4-diamine
1-(4-chlorophenyl)-3-[(2S,3R,6S)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(4-chlorophenyl)-3-[(2R,3R,6R)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(4-chlorophenyl)-3-[(2S,3S,6S)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(4-chlorophenyl)-3-[(2R,3S,6R)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(4-chlorophenyl)-3-[(2S,3S,6R)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(4-chlorophenyl)-3-[(2S,3R,6R)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(4-chlorophenyl)-3-[(2R,3S,6S)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(4-chlorophenyl)-3-[(2R,3R,6S)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
[(1R)-7-methoxy-9-methyl-2-methylsulfonyl-1-(4-oxanylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
(4S)-4-N-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]pentane-1,4-diamine
N-[3-(1H-benzimidazol-2-yl)-5-(1-piperazinylmethyl)phenyl]-2-quinoxalinecarboxamide
1-[3-(Diethylamino)propyl]-4-(7-methoxy-1-benzofuran-2-carbonyl)-5-pyridin-4-ylpyrrolidine-2,3-dione
(2,5-Dioxopyrrolidin-1-yl) 3-[3-(ethylamino)-6-ethylimino-2,7-dimethylxanthen-9-yl]propanoate
estra-1,3,5(10)-triene-3,16alpha,17beta-triol 17-D-glucuronide
Takeda103A
Takeda103A is a potent inhibitor of GRK2. G protein-coupled receptors (GPCRs) are central to many physiological processes. Takeda103A has the potential for the research of heart failure[1].